A common virus carried by most humans could trigger lupus, offering new clues for preventing and treating this dangerous ...

A new study examined whether routine blood test measures could help in identifying disease flares in people with systemic ...

FT819 continues to demonstrate meaningful decrease in disease and favorable safety profile with twelve systemic lupus erythematosus (SLE) ...

Data show deep, durable responses in the 50 million cell dose level cohort; initial data suggest substantial early improvement in three patients ...

Dermatologists long reluctant to tackle cutaneous lupus erythematosus may be more open to treating patients with approvals ...

Self-care, structured exercise, and reliable medication adherence help stabilize systemic lupus erythematosus and reduce long ...

Detailed mapping of CD4⁺ T cells from children with systemic lupus erythematosus (SLE) has revealed distinct immune cell ...

Roche has received approval from the European Commission (EC) for its humanised monoclonal antibody Gazyva/Gazyvaro ...

Approval based on phase II NOBILITY and phase III REGENCY studies showing superiority of Gazyva/Gazyvaro over standard ...

Lupus is a serious autoimmune disease in dogs. It causes the dog's immune system to attack its tissues on a cellular level. Humans can also contract this disease; however, lupus often causes ...

FT819 continues to demonstrate meaningful decrease in disease and favorable safety profile with twelve systemic lupus ...

Data show deep, durable responses in the 50 million cell dose level cohort; initial data suggest substantial early improvement in three patients dosed with 100 million cellsAll patients show deep ...